Hsbc Holdings PLC Makes New Investment in iShares Biotechnology ETF $IBB

Hsbc Holdings PLC bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 3,158 shares of the financial services provider’s stock, valued at approximately $534,000.

A number of other hedge funds also recently added to or reduced their stakes in IBB. Rockefeller Capital Management L.P. lifted its position in iShares Biotechnology ETF by 16.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 147,707 shares of the financial services provider’s stock valued at $24,929,000 after purchasing an additional 21,052 shares during the last quarter. World Investment Advisors grew its position in iShares Biotechnology ETF by 50.4% in the 4th quarter. World Investment Advisors now owns 11,853 shares of the financial services provider’s stock worth $2,001,000 after purchasing an additional 3,973 shares during the last quarter. Green Ridge Wealth Planning LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $295,000. Audent Global Asset Management LLC increased its stake in shares of iShares Biotechnology ETF by 10.0% in the fourth quarter. Audent Global Asset Management LLC now owns 24,617 shares of the financial services provider’s stock valued at $4,155,000 after purchasing an additional 2,231 shares during the period. Finally, Corient Private Wealth LLC increased its stake in shares of iShares Biotechnology ETF by 113.6% in the fourth quarter. Corient Private Wealth LLC now owns 62,227 shares of the financial services provider’s stock valued at $10,503,000 after purchasing an additional 33,099 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.2%

IBB opened at $189.51 on Friday. The business’s 50 day moving average is $177.39 and its 200-day moving average is $173.28. iShares Biotechnology ETF has a twelve month low of $128.84 and a twelve month high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were given a $0.0238 dividend. This represents a $0.10 annualized dividend and a yield of 0.1%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.